Abiopharma

Autozi Internet Technology (Global) Ltd. (Nasdaq: AZI) Announces Letter of Intent for Proposed Reverse Takeover Transaction with Privately Held Operating Company

Cycurion Confirms August 20 Nasdaq Hearing Date; Common Stock Continues Trading on Nasdaq

Net Asset Value(s)

nLIGHT Announces Participation in Upcoming Investor Events

bioAffinity Technologies Reports Second Quarter 2026 Results and Continued Strong Commercial Momentum for CyPath® Lung

Ouster Announces Upcoming Investor Events

Humacyte To Announce 2026 Second Quarter Financial Results and Provide Business Update on August 12, 2026

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Viking Takes Delivery of Newest Egypt Ship